Latest News

Rapid-acting antidepressant for treatment-resistant depression: New insights

Researchers have generated fresh insights that could aid in the development of rapid-acting antidepressants for treatment-resistant depression. The researchers found that by blocking NMDA receptors with the drug ketamine, they could elicit rapid antidepressant effects in patients with treatment-resistant depression. Ketamine was developed as an anesthetic, but is better known publicly for its abuse as the party drug Special K. Researchers are now seeking alternatives because ketamine can produce side effects that include hallucinations and the potential for abuse -- limiting its utility as an antidepressant.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • U.S. public sees ill health as resulting from a broad range of causes, poll suggests

  • Traditional beliefs promote sustainability in West Africa

  • Mechanism behind most common form of inherited Alzheimer's disease revealed

  • Using fruit flies to understand how we sense hot and cold

  • Older, white males with advanced bladder cancer at high risk for suicide

  • Time management: Why we feel busier when close to reaching a goal

  • Strong genetic risk factor for MS discovered in family of five affected siblings

  • New information on Parkinson?s: GDNF not needed by the midbrain dopamine system

  • Men tend to be more narcissistic than women, study finds

  • Marriages more likely to end in divorce when wives get sick

  •